Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer

Launched by RENJI HOSPITAL · Feb 18, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on creating a detailed database to better understand gallbladder cancer, which is a type of cancer that affects the gallbladder. Researchers want to gather information about how this cancer is diagnosed and treated in real-world settings. The goal is to improve future treatments by using this data to help doctors provide more personalized care for patients with gallbladder cancer.

To participate in this study, individuals must be between 18 and 74 years old and have a diagnosis of gallbladder cancer. Participants will need to sign a consent form and agree to provide follow-up information and blood samples. However, those with certain health issues or who are pregnant or breastfeeding will not be eligible. While the trial is not yet recruiting, it aims to collect valuable information that could lead to better treatment options for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Sign informed consent, have good compliance, and be willing to accept follow-up and provide blood samples
• • Age 18-74 years old, gender is not limited
• • Clinical diagnosis of gallbladder cancer, including unoperated patients preliminarily diagnosed as gallbladder cancer according to the results of imaging examinations and laboratory tests, or pathological examination of patients treated with surgery confirmed as malignant tumors of the gallbladder.
• • The primary tumor is located in gallbladder floor, gallbladder body, gallbladder neck or gallbladder duct.
• • Karnofsky performance score greater than 50.
• Exclusion Criteria:
• • Patients with gallbladder cancer, gallbladder cancer foci are not primary lesions.
• • Patients with gallbladder cancer, combined with serious central nervous system diseases, respiratory diseases, autoimmune diseases, chronic renal insufficiency and other diseases, long-term use of immunosuppressants, combined with serious uncontrolled infections.
• • Patients with gallbladder cancer, who also have active cardiovascular and cerebrovascular diseases, have cerebrovascular accidents, myocardial infarction, unstable angina pectoris, or grade II. or above congestive heart failure according to the standards of the New York Heart Association, and require serious arrhythmias requiring drug treatment.
• • Patients with gallbladder cancer, women of childbearing age who have a positive blood pregnancy test or have not had a pregnancy test, pregnant or breastfeeding women.
• • The patient is participating in other therapeutic clinical trials where treatment measures cannot be clarified or treatment information cannot be collected .